Literature DB >> 19959639

Suppression of bystander T helper 1 cells by iris pigment epithelium-inducing regulatory T cells via negative costimulatory signals.

Sunao Sugita1, Shintaro Horie, Yukiko Yamada, Hiroshi Keino, Yoshihiko Usui, Masaru Takeuchi, Manabu Mochizuki.   

Abstract

PURPOSE: To determine whether iris pigment epithelium (IPE)-induced T regulatory (Treg) cells can suppress the activation of bystander T cells with cell contact via costimulatory interactions.
METHODS: CD8(+) T cells were cocultured with IPE, x-irradiated, and then used as regulators (IPE-induced Treg cells). The target CD4(+) T cells from wild-type control or knockout donors were used for the assay. T-cell activation was assessed for proliferation by examining both [(3)H]-thymidine incorporation and cytokine production. Expression of costimulatory molecules on IPE-induced Treg cells was evaluated using RT-PCR, immunostaining, and flow cytometry. Expression of costimulatory receptors on target T cells or Treg cells was evaluated by flow cytometry. Neutralizing antibodies were then used to abolish regulatory function.
RESULTS: CD8(+) IPE-induced Treg cells significantly suppressed the activation of effector target T cells, e.g., T-cell proliferation and cytokine production such as Th1, Th2, and Th17 cytokines. Although IPE-induced Treg cells expressed various costimulatory molecules, including programmed cell death 1 ligand 1 (PD-L1), only PD-L1 on the Treg cells was actually delivered to target Th1 cells using cell-to-cell interaction (T-T interaction). If neutralizing antibodies for PD-L1 were cocultured with Treg cells, Th1 suppression was impaired. Moreover, Treg cells failed to suppress IFNgamma production by target CD4(+) T cells from programmed cell death 1 (PD-1) knockout donors. Th1-specific inhibition was exclusively achieved with direct cell contact.
CONCLUSIONS: T cells exposed to IPE in the eye that acquires full regulatory capacity express negative costimulators and suppress bystander Th1-type effector cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19959639     DOI: 10.1167/iovs.09-4460

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

1.  Immune checkpoint inhibitors and corneal transplant rejection: a call for awareness.

Authors:  Harpal Singh Sandhu; Houman D Hemmati; Reza Dana
Journal:  Immunotherapy       Date:  2020-08-25       Impact factor: 4.196

2.  Suppressive effect of aqueous humor on lipopolysaccharide-induced dendritic cell maturation.

Authors:  Hui-Fang Wang; Jin-Ling Liu; Xin-Li Jiang; Jian-Min Lu; Xiao-Lei Li; Xiu-Jun Song
Journal:  Jpn J Ophthalmol       Date:  2011-07-20       Impact factor: 2.447

3.  Good news-bad news: the Yin and Yang of immune privilege in the eye.

Authors:  John V Forrester; Heping Xu
Journal:  Front Immunol       Date:  2012-11-27       Impact factor: 7.561

Review 4.  Immune Privilege and Eye-Derived T-Regulatory Cells.

Authors:  Hiroshi Keino; Shintaro Horie; Sunao Sugita
Journal:  J Immunol Res       Date:  2018-05-20       Impact factor: 4.818

Review 5.  The Cellular Composition of the Uveal Immune Environment.

Authors:  Ian R Reekie; Srilakshmi Sharma; Andrew Foers; Jonathan Sherlock; Mark C Coles; Andrew D Dick; Alastair K Denniston; Christopher D Buckley
Journal:  Front Med (Lausanne)       Date:  2021-10-29

6.  Influence of CD8+ T regulatory cells on intraocular tumor development.

Authors:  Kyle C McKenna; Dana M Previte
Journal:  Front Immunol       Date:  2012-09-28       Impact factor: 7.561

Review 7.  Immunotherapeutic strategies in autoimmune uveitis.

Authors:  Pedro Henrique Papotto; Eliana Blini Marengo; Luiz Roberto Sardinha; Anna Carla Goldberg; Luiz Vicente Rizzo
Journal:  Autoimmun Rev       Date:  2014-05-12       Impact factor: 9.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.